Senores Pharmaceuticals Ltd - 544319 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

Senores Pharmaceuticals Ltd.

NSE: SENORES | BSE: 544319 | ISIN: INE0RB801010 | Industry: Pharmaceuticals
| Expensive Performer

712.7000 16.20 (2.33%)

NSE Sep 03, 2025 15:31 PM

Near 52W High of ₹737.85

Volume: 210.8K

Senores Pharmaceuticals Ltd.

20 Feb 2025

712.70

2.33%

Company Update

Senores Pharmaceuticals Ltd - 544319 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

BSE India

Media Release - Senores Pharmaceuticals acquires ANDA for Roflumilast 250 mcg and 500 mcg tablets.

More from Senores Pharmaceuticals Ltd.

Recommended

Market closes higher, Netweb Tech wins a Rs 1,734 cr IndiaAI Mission order for sovereign AI system

Trendlyne Marketwatch | 03 Sep 2025, 03:59PM

Five stocks to buy from analysts this week - September 2, 2025

The Baseline | 02 Sep 2025, 06:04PM

IPO activity stays steady with Amanta and seven SME issues opening this week

| 02 Sep 2025, 11:38AM